Profile
New Horizon Capital is a private equity firm based in China, founded in 2005. The firm focuses on growth and expansion investments, primarily in the Chinese market. Led by Managing Partner and Co-Founder Jianming Yu, New Horizon Capital has a team of experienced professionals with a strong track record in deal execution and investment management.
The firm invests in sectors such as advanced manufacturing, alternative energy, consumer products and services, and healthcare. It targets opportunities in less developed Tier II and Tier III regions of China, aiming to leverage the rapid economic development in these areas. New Horizon Capital manages several funds, including New Horizon Capital IV, a $1.05 billion fund launched in 2012, which focuses on consumer durables, TMT, consumer electronics, and manufacturing industries.
Notable investments by New Horizon Capital include MEDx (Suzhou) - drug discovery, YOUNGZONE (Shanghai) - educational software, XueLeYun Education - educational software, Zhao Suliao - media and information services, and HS Entertainment - movies, music, and entertainment.
Industry
New Horizon Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
New Horizon Capital IV
|
Private Equity (PE)
|
Consumer Products
Consumer Services (B2C)
Healthcare Services
Industrial
|
Series B
Late Stage (Series C+)
|
Asia
|
$50-100 m
|
$1050 M
|
January 2012
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.